Literature DB >> 2040474

Prognosis in familial non-polyposis colorectal cancer.

F Kee1, B J Collins, C C Patterson.   

Abstract

Familial cases of non-polyposis colorectal cancer have attracted much interest but little is known of their natural history. Using a population based study we have determined whether a positive family history of bowel cancer is an independent prognostic factor. All patients under 55 years with histologically confirmed colorectal cancer in Northern Ireland during the period 1976-8 were studied. The family history was validated in 95% of all nonpolyposis cases (n = 205). Medical history or cause of death were verified for 98% of 1811 first degree relatives. The strength of the family history was assessed using a score that compares the mortality from bowel cancer in the family against the average population mortality, taking account of family size and age structure. The family history score was not predictive of survival neither in univariate analysis or in a Cox's proportional hazards multivariate analysis controlling for age, sex, stage, site, and duration of symptoms. In conclusion, a positive family history does not independently influence prognosis in patients with bowel cancer.

Entities:  

Mesh:

Year:  1991        PMID: 2040474      PMCID: PMC1378928          DOI: 10.1136/gut.32.5.513

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Factors affecting compliance with screening for colorectal cancer.

Authors:  P A Farrands; J D Hardcastle; J Chamberlain; S Moss
Journal:  Community Med       Date:  1984-02

2.  Factors associated with speed of diagnosis, referral, and treatment in colorectal cancer.

Authors:  C MacArthur; A Smith
Journal:  J Epidemiol Community Health       Date:  1984-06       Impact factor: 3.710

3.  Small bowel cancers, B-cell lymphatic leukemia, and six primary cancers with metastases and prolonged survival in the cancer family syndrome of Lynch.

Authors:  R R Love
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

4.  A comparison of positive family history definitions for defining risk of future disease.

Authors:  S C Hunt; R R Williams; G K Barlow
Journal:  J Chronic Dis       Date:  1986

5.  [Comparison of tumor incidence in 251 first-degree relatives of 50 patients with colorectal carcinoma with those of the Basel population].

Authors:  W Weber; B Voegtli; M Buser; A Gencik; L Kayasseh; G A Stalder; J Torhorst; H Müller
Journal:  Schweiz Med Wochenschr       Date:  1985-07-20

6.  Outcome in colorectal carcinoma: seven-year study of a population.

Authors:  D N Clarke; P F Jones; C D Needham
Journal:  Br Med J       Date:  1980-02-16

7.  The analysis of mortality by the subject-years method.

Authors:  G Berry
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

8.  Clinical features of colorectal carcinoma in cancer family syndrome.

Authors:  J P Mecklin; H J Järvinen
Journal:  Dis Colon Rectum       Date:  1986-03       Impact factor: 4.585

9.  Familial heterogeneity of colon cancer risk.

Authors:  H T Lynch; W J Kimberling; K A Biscone; J F Lynch; C A Wagner; K Brennan; J A Mailliard; P S Johnson; J S Soori; P J McKenna
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

10.  Characteristics of familial colon cancer in a large population data base.

Authors:  L A Cannon-Albright; T C Thomas; D T Bishop; M H Skolnick; R W Burt
Journal:  Cancer       Date:  1989-11-01       Impact factor: 6.860

View more
  2 in total

1.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent?

Authors:  A J Clark; R Barnetson; S M Farrington; M G Dunlop
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.